The U.S. death toll from the coronavirus illness COVID-19 climbed above 115,000 on Monday, and the stock market tanked amid growing concerns about the uptick...
The company said it is sponsoring a 400-patient randomized trial to confirm whether the drug Olumiant can moderate Covid symptoms.
Incyte Launches New Global Responsibility Section on Incyte.com
Shares of Eli Lilly & Co. undefined were down 1.1% in premarket trading on Monday after the drugmaker said the first patient had been enrolled in a...
Shares of Eli Lilly & Co. were down 1.1% in premarket trading on Monday after the drugmaker said the first patient had been enrolled in a late-stage trial assessing rheumatoid arthritis drug Olumiant
The chart filled in by biochemists and preserved by the U.S. National Library of Medicine shows how complicated it was to figure out the universal code behind the cells of living organisms. Other …
Incyte Launches New Global Responsibility Section on Incyte.com
Whether the latest data on the experimental drug for myelofibrosis patients is good or bad news depends on your point of view.
Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re
It's a 144-year-old big pharma...but it's quickly become the leader in a key area of fighting COVID-19.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE